SJ
Sudha Jain
About Sudha Jain
Data last updated:
Sudha Jain is a Director at Rx Plus Pharmaceuticals Private Limited (since 2023). The companies operate in Home Appliances and Construction. Rx Plus Pharmaceuticals Private Limited reported revenue of ₹30.6 Lakh (FY 2025). Earlier, Sudha Jain was a Designated Partner at Stelfliers Global Llp (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rx Plus Pharmaceuticals Private Limited U51397DL2023PTC409712 | Director | 10 Jan 2023 | 2023 | ₹30.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Stelfliers Global Llp ABA-3704 | Designated Partner | 25 Jan 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sudha Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhinav Jain | 09479829 | Rx Plus Pharmaceuticals Private Limited | Director |
| Parveen | 08618778 | Rx Plus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudha Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudha Jain
Sudha Jain currently holds 1 directorship: Rx Plus Pharmaceuticals Private Limited (Director, since 10 Jan 2023, revenue ₹30.6 Lakh (FY 2025)).
Sudha Jain was first appointed on 25 Jan 2022 as Designated Partner at Stelfliers Global Llp. The most recent appointment on record is 10 Jan 2023 at Rx Plus Pharmaceuticals Private Limited.
Sudha Jain held 1 earlier board appointment: Stelfliers Global Llp (Designated Partner, 25 Jan 2022 to 12 Feb 2025).
The current boards of Sudha Jain's companies include Abhinav Jain (Rx Plus Pharmaceuticals Private Limited), Parveen (Rx Plus Pharmaceuticals Private Limited).